The assay is a direct competitive EIA for the quantitative measurement
of Estradiol in human serum or plasma. A specific agent displaces
Estradiol from binding proteins, making it available for antibody binding.
Estradiol then reacts successively with an anti-Estradiol antibody linked
to fluorescein isothiocyanate (FITC) and alkaline phosphatase labelled
Estradiol . An anti-FITC antibody bound to magnetic particles then
separates the estradiol/estradiol label-antibody complex from unbound
components. A further incubation with substrate produces colour in inverse
proportion to the amount of estradiol present. The assay has five main
stages:
Displacing agent and anti-estradiol antibody conjugated to
FITC are incubated with sample
(150 µL) for 20 minutes at 37°C.
Alkaline phophatase labelled estradiol tracer is added and
the incubation continued for a
further 20 minutes at 37°C.
Anti-FITC antibody coupled to magnetic particles is added
and incubated for 5 minutes at
37°C. Anti-estradiol antibody is then isolated by means of a
magnetic wash step.
A coloured enzyme substrate is incubated with the particles for
30 minutes at 37°C. The presence of alkaline phosphatase causes a
colour change from yellow to pink.
The reaction is terminated by addition of Stop Solution.
The tubes are then placed in the spectrophotometer or colorimeter.
The optical density (at 550nm) of each tube can be measured and the
results calculated using a data processing program.